NeuoKaire develops a personalized medical testing tool to better treat depression.
NeuroKaire has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.
NeuroKaire's investors include European Innovation Council, MassChallenge, Meron Capital, Jumpspeed Ventures, Howard Morgan.
NeuroKaire is headquartered in Tel Aviv-yafo, Israel.
NeuoKaire develops a personalized medical testing tool to better treat depression.
NeuroKaire is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeuroKaire — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/neurokaire. Accessed July 20, 2026.
VCBacked. (2024). NeuroKaire — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/neurokaire
{{cite web |title=NeuroKaire — Funding & Investors |url=https://www.vcbacked.co/company/neurokaire |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated